NCT00800241已完成不适用
Budesonide/Formoterol for Maintenance and Reliever Therapy: A Medication Use Evaluation Among Persistent Asthma Patients in General Practice in Thailand
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,020
- 试验地点
- 1
- 主要终点
- Number of budesonide/formoterol use per patient
研究概览
简要总结
The purpose of this study is to determine the incidence of misuse, i.e., over-use and under-use, of Budesonide/formoterol for maintenance and reliever therapy in usual-care setting.
研究设计
- 研究类型
- Observational
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Established persistent asthma
- •Currently treated with Symbicort SMART for 3 months or longer
排除标准
- •currently participating or have participated in a study with an investigational compound within the last 30 days
- •current diagnosis of chronic obstructive pulmonary disease (COPD)
- •smoked more than 10 pack-year
结局指标
主要结局
Number of budesonide/formoterol use per patient
时间窗: On the survey date
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice.AsthmaNCT04835961Elpen Pharmaceutical Co. Inc.1,037
已完成
3 期
Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®AsthmaNCT01803555Teva Branded Pharmaceutical Products R&D, Inc.605
已完成
不适用
The effects of budesonide/formoterol maintenance and reliever therapy on airway inflammation in asthma patients; open label, randomized parallel group comparison study with fluticasone/salmeterolBronchial asthmaJPRN-UMIN000011241Hiroshima Allergy and Respiratory Clinic30
已完成
3 期
As-needed Budesonide/Formoterol Turbuhaler in Stepping Down PeriodAsthmaNCT04215848Hat Yai Medical Education Center31
已完成
3 期
Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial AsthmaAsthmaNCT00232648AstraZeneca54